APAC Drug Delivery Devices Market

APAC Drug Delivery Devices Market Size (2024 to 2029)

The Drug Delivery Devices Market size in the Asia Pacific region was valued at USD 245.88 Million in 2024 and is expected to be USD 346.47 Million by 2029, growing at a CAGR of 7.1% during the forecast period.

There are many growth contributing factors responsible for market growth in terms of the drug delivery devices market. Drug delivery devices are medical equipment used for introducing a drug into human bodies and various systems in human bodies. Various routes of administration techniques do the administration of a drug into human bodies. Factors such as an increase in the prevalence of chronic diseases, the spread of infections, increased population where the pediatric and geriatric ratio contributes to the market's growth. Other factors, such as the increased adaption of therapeutic medicines and surgeries, increased awareness of early detection of diseases, and treatment, also increase the market growth. These devices are most often therapeutically used. Developed research activities across the country, technological advancements are observed in the forecast period and are major market drivers. Government initiatives towards creating awareness in public about early detection of diseases and its treatment, fundraisings from NGOs, and the public drive growth for this market.  

For handling and associating with these devices and equipment, a lot of caring and staff are required. Skilled persons, professionals are always needed to carry out these processes. Increased complications associated with delivering and manufacturing medicines hamper the market growth. Administrating selected drugs to targeted sites is hard to achieve. There are also a lot of safety concerns with this market. There are stringent regulations, and the approval committee for providing grants for these devices makes this market more challenging to achieve its goals.

This research report on the Asia-Pacific Drug Delivery Devices Market has been segmented and sub-segmented into the following categories:

• By Route of Administration: Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Tran mucosal Drug Delivery.
• By End-User: Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers.
• By Region: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis: 

The Asia Pacific expects the highest market growth during the forecast period. China and Japan regions are noted as highly populated across Asia pacific. Hence the rise in populations leads to demand for the availability of drugs and drug-delivering devices. In regions like India, the government has brought up many initiatives to support health care and patient safety. It raises awareness in the public about the early detection of diseases and their treatment. Hence the drug administration process is monetarily done. Increased technological developments, research activities, rise in investors, and public funders for this market, increased demand for pharmaceutical industries contribute to the growth of the drug delivery devices market in the Asia Pacific region. 

Some of the Prominent Companies leading the Asia-Pacific Drug Delivery Devices Market Profiled in the Report are Bend Research, Endocyte, Microchips Inc., Pearl Therapeutics Inc., Presage Bioscience, UCB Group, Genentech Inc., Polymer Factory, Alkermes Inc., BIND Biosciences Inc., and QLT Inc.